CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 34 enrolled
Drug / intervention
Biofeedbackbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03692624
NCT03692624N/ACompleted
CompareCT.gov

Use of Heart Rate Variability (HRV) Biofeedback for Symptom Management Among Cancer Survivors: Pilot Intervention

Prisma Health-Upstate·interventional·Posted Oct 2, 2018·Updated Mar 6, 2020

In Brief

A clinical study evaluating Biofeedback for Cancer. Completed, enrolled 34 participants across 1 site.

Detailed Summary

Heart rate variability biofeedback (HRV-B) is a complementary, non-pharmacologic therapy that is being tested to see if it can help cancer survivors reduce their symptoms of pain, stress, insomnia, fatigue, or depression. HRV-B is an interactive procedure in which participants relax and breathe regularly while watching the a computer screen. The computer screen provides feedback that helps people increase their heart rate variability.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCancer
CountriesUnited States
CollaboratorsUniversity of South Carolina

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedOct 2, 2018
Enrollment StartMay 10, 2015
Primary CompletionApr 19, 2017
Study CompletionFeb 7, 2020
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 7.8 years ago

Interventions

Biofeedbackbehavioral

Heart Rate Variability Biofeedback